Quince Therapeutics (QNCX) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.34
-0.29
-0.23
-0.18

Details

Expected EPS
-0.215
Actual EPS
-0.25
Surprise EPS
-0.04
Surprise Percent
+16.28%

Description

Quince Therapeutics (QNCX) has reported earnings of -0.25 per share for Q4 2025.

0 Comments

Share your thoughts